Compare Abbott India with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SHASUN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SHASUN PHARMA ABBOTT INDIA/
SHASUN PHARMA
 
P/E (TTM) x 48.3 123.9 39.0% View Chart
P/BV x 15.6 8.5 183.0% View Chart
Dividend Yield % 0.4 0.2 188.9%  

Financials

 ABBOTT INDIA   SHASUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
SHASUN PHARMA
Mar-14
ABBOTT INDIA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs8,83494 9,378.0%   
Low Rs5,45846 11,968.2%   
Sales per share (Unadj.) Rs1,731.1214.2 808.2%  
Earnings per share (Unadj.) Rs211.95.3 3,971.6%  
Cash flow per share (Unadj.) Rs219.915.8 1,389.9%  
Dividends per share (Unadj.) Rs65.001.00 6,500.0%  
Dividend yield (eoy) %0.91.4 63.6%  
Book value per share (Unadj.) Rs945.253.3 1,772.0%  
Shares outstanding (eoy) m21.2556.62 37.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.3 1,264.8%   
Avg P/E ratio x33.713.1 257.4%  
P/CF ratio (eoy) x32.54.4 735.5%  
Price / Book Value ratio x7.61.3 576.9%  
Dividend payout %30.718.7 163.7%   
Avg Mkt Cap Rs m151,8483,958 3,836.7%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,3562,164 201.3%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,78612,127 303.3%  
Other income Rs m1,133229 494.0%   
Total revenues Rs m37,91912,356 306.9%   
Gross profit Rs m6,0471,009 599.3%  
Depreciation Rs m169594 28.5%   
Interest Rs m23415 5.4%   
Profit before tax Rs m6,989230 3,042.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485-73 -3,417.5%   
Profit after tax Rs m4,503302 1,490.6%  
Gross profit margin %16.48.3 197.6%  
Effective tax rate %35.6-31.7 -112.3%   
Net profit margin %12.22.5 491.4%  
BALANCE SHEET DATA
Current assets Rs m27,6106,884 401.0%   
Current liabilities Rs m8,5698,456 101.3%   
Net working cap to sales %51.8-13.0 -399.4%  
Current ratio x3.20.8 395.8%  
Inventory Days Days6062 97.7%  
Debtors Days Days27108 25.5%  
Net fixed assets Rs m1,0574,970 21.3%   
Share capital Rs m213113 187.6%   
"Free" reserves Rs m19,8732,875 691.3%   
Net worth Rs m20,0863,020 665.0%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m29,40913,347 220.3%  
Interest coverage x311.61.6 20,059.7%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.9 137.7%   
Return on assets %15.45.4 286.4%  
Return on equity %22.410.0 224.1%  
Return on capital %34.913.3 262.0%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m3695,843 6.3%   
Fx outflow Rs m4,9182,173 226.3%   
Net fx Rs m-4,5493,669 -124.0%   
CASH FLOW
From Operations Rs m4,991398 1,255.4%  
From Investments Rs m-2,570-1,635 157.2%  
From Financial Activity Rs m-1,4281,309 -109.1%  
Net Cashflow Rs m99371 1,395.1%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.6 219.4%  
FIIs % 0.1 17.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 39.6 43.2%  
Shareholders   18,270 20,750 88.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Mar 5, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - CADILA HEALTHCARE COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS